Additional file 2: of Use of glatiramer acetate between 2010â2015: effectiveness, safety and reasons to start GA as first or second line treatment in Swiss multiple sclerosis patients

12883_2019_1383_MOESM2_ESM.docx (14.45 kB)

Additional file 2: of Use of glatiramer acetate between 2010â2015: effectiveness, safety and reasons to start GA as first or second line treatment in Swiss multiple sclerosis patients

journal contribution

posted on 2019-07-12, 05:00 authored by Chiara Zecca, Giulio Disanto, Rosaria Sacco, Gianna Riccitelli, Claudio Gobbi

Adverse events reported during study period. (DOCX 14 kb)

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC